REITHERA

🚀𝗗𝗮𝘆 𝟭 𝗼𝗳 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗟𝗼𝗻𝗱𝗼𝗻 𝗶𝘀 𝗵𝗲𝗿𝗲!  🚀 ReiThera is excited to kick off #AdvancedTherapies2025 in London! Our team—Claudio Panzarella (Head of Business Development), Michela Gentile, PhD Gentile (Technology Development Supervisor), and Francesca Vidali (Marketing Specialist)—is ready to welcome you at 𝗕𝗼𝗼𝘁𝗵 𝟵𝟰. Whether you're interested in discussing cutting-edge innovations in genetic and cell therapies or exploring potential collaborations, we'd love to connect. Stop by to learn more about REITHERA’s expertise and how we’re shaping the future of advanced therapies! See you at Booth 94! 🔬💡 #AdvancedTherapies #Biotech #CellAndGeneTherapy #ReiThera #Networking

🚀 𝗚𝗥𝗔𝗱 𝗣𝗟𝗔𝗧𝗙𝗢𝗥𝗠: 𝗣𝘂𝘀𝗵𝗶𝗻𝗴 𝘁𝗵𝗲 𝗕𝗼𝘂𝗻𝗱𝗮𝗿𝗶𝗲𝘀 𝗼𝗳 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻! 🦍💉 At 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮, we’re redefining genetic vaccine development with our proprietary GRAd platform—an advanced adenoviral vector derived from a captive gorilla, designed for strong immunogenicity, low seroprevalence, and enhanced thermostability. Why does 𝗚𝗥𝗔𝗱 stand out? ✅ 𝗟𝗼𝘄 𝗣𝗿𝗲𝘃𝗮𝗹𝗲𝗻𝗰𝗲 𝗶𝗻 𝗛𝘂𝗺𝗮𝗻𝘀 – Unlocks a more effective immune response. ✅ 𝗛𝗶𝗴𝗵 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗣𝗼𝘁𝗲𝗻𝗰𝘆 – Clinically validated for vaccine development. ✅ 𝗧𝗵𝗲𝗿𝗺𝗼𝘀𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗮𝘁 +𝟰°𝗖 𝗮𝗻𝗱 𝟯𝟳°𝗖 – Facilitates storage and distribution. ✅ 𝗦𝗰𝗮𝗹𝗮𝗯𝗹𝗲 & 𝗖𝗼𝘀𝘁-𝗘𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 – GMP-validated production for small to large batches. From infectious diseases to oncology and beyond, GRAd is empowering the next generation of vaccines. 🦠🔬 💡 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲? 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝘂𝘀 𝗼𝗿 𝘃𝗶𝘀𝗶𝘁 𝗼𝘂𝗿 𝗯𝗼𝗼𝘁𝗵 𝗮𝘁 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗟𝗼𝗻𝗱𝗼𝗻, 𝗕𝗼𝗼𝘁𝗵 𝟵𝟰! #ReiThera #GRAdPlatform #VaccineInnovation #Biotech #GeneticVaccines

🚨 𝗢𝗻𝗲 𝗪𝗲𝗲𝗸 𝘁𝗼 𝗚𝗼! 𝗠𝗲𝗲𝘁 𝗢𝘂𝗿 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗦𝘂𝗽𝗲𝗿𝘃𝗶𝘀𝗼𝗿 𝗮𝘁 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝟮𝟬𝟮𝟱 🚨 The countdown is on—𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝟮𝟬𝟮𝟱 𝗶𝘀 𝗷𝘂𝘀𝘁 𝗼𝗻𝗲 𝘄𝗲𝗲𝗸 𝗮𝘄𝗮𝘆! ⏳ Don’t miss the chance to meet our Technology Development Supervisor, Michela Gentile, PhD Gentile, at Booth #94. Michela will be there to discuss the latest advancements in technology development for cell and gene therapies, share insights, and explore potential collaborations. 📅 Only One Week to Go! 📍 Booth: #94 🤝 Let’s connect—schedule a meeting or drop by! We’re looking forward to insightful conversations and groundbreaking innovations. See you in a week! 🚀 #AdvancedTherapies #TechnologyDevelopment #Innovation #CellAndGeneTherapy #Biotech #Networking

On International Women’s Day we are celebrating the amazing women who are a part of the MAGIC project. 👩🔬 These MAGICians play a vital role in the projects goal of developing effective treatments for people living with muscular dystrophies. From speeding up research progress, to working with partners from all around the globe, to learning new techniques, our team is dedicated to driving real-world change. Hear from some of these talented women as they talk about the importance of the MAGIC project and the impact it could have. 🔗 Find out more: https://lnkd.in/dVJb3T_W #InternationalWomensDay #IWD2025 #MuscularDystrophy #GeneTherapies

𝗧𝗼𝗺𝗼𝗿𝗿𝗼𝘄 𝗶𝘀 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗺𝗲𝗻'𝘀 𝗗𝗮𝘆, 𝗯𝘂𝘁 𝗮𝘁 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮, 𝘄𝗲 𝗰𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗲 𝗮𝗻𝗱 𝗲𝗺𝗽𝗼𝘄𝗲𝗿 𝘄𝗼𝗺𝗲𝗻 𝗲𝘃𝗲𝗿𝘆 𝘀𝗶𝗻𝗴𝗹𝗲 𝗱𝗮𝘆. Women still face significant challenges in the workplace—whether it’s the persistent gender pay gap, underrepresentation in leadership, or biases that make it harder to be valued. In fact, studies show that in many industries, women still earn less than men for the same roles, and many people remain unaware of how deep these inequalities run. That’s why we’re proud to be a company where women are not only well-represented but are also driving innovation—many of them young professionals shaping the future of biotech. 𝗧𝗵𝗶𝘀 𝘀𝗵𝗼𝘂𝗹𝗱 𝗻𝗼𝘁 𝗯𝗲 𝗮𝗻 𝗲𝘅𝗰𝗲𝗽𝘁𝗶𝗼𝗻; 𝗶𝘁 𝘀𝗵𝗼𝘂𝗹𝗱 𝗯𝗲 𝘁𝗵𝗲 𝗻𝗼𝗿𝗺. At ReiThera, we believe in real equality, every day—not just on March 8th. Let’s continue to challenge biases, break barriers, and celebrate women’s resilience all year round. 💜 #IWD2025 #GenderEquality #WomenInScience #EverydayIsWomensDay

🚀 𝗠𝗲𝗲𝘁 𝗢𝘂𝗿 𝗛𝗲𝗮𝗱 𝗼𝗳 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝘁 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝟮𝟬𝟮𝟱! 🚀 We’re excited to announce that our Head of Business Development, Claudio Panzarella, will be attending Advanced Therapies 2025 at Booth #94! This is a great opportunity to connect and discuss the latest innovations, challenges, and opportunities in cell and gene therapies. Whether you're looking to explore partnerships, dive into cutting-edge advancements, or just have a great conversation—Claudio will be there to engage. 📅 𝗘𝘃𝗲𝗻𝘁: 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝟮𝟬𝟮𝟱 📍 𝗕𝗼𝗼𝘁𝗵: #𝟵𝟰 🤝 Let’s connect! Drop by or send us a message to schedule a meeting in advance. See you there! #AdvancedTherapies #BusinessDevelopment #Networking #CellAndGeneTherapy #Biotech

Stiamo #assumendo per un ruolo di “PD Upstream Scientist” a Greater Rome Metropolitan Area. Candidati subito o condividi questo post con la tua rete.

We truly appreciated this initiative! It was a pleasure to welcome the students for a tour at REITHERA and share our presentation with them. Thank you for joining us and engaging with our work—together, we're shaping the future of cell and gene therapies.

🚀 𝗗𝗜𝗦𝗖𝗢𝗩𝗘𝗥 𝗧𝗛𝗘 𝗣𝗢𝗪𝗘𝗥 𝗢𝗙 𝗢𝗨𝗥 𝗠𝗩𝗔 𝗣𝗟𝗔𝗧𝗙𝗢𝗥𝗠! 🧬🔬 At 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮, we’re pushing the boundaries of genetic vaccine development with our cutting-edge 𝗠𝗩𝗔 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Whether you're looking for a trusted partner or the latest technology, we've got you covered. Want to know what makes our platform stand out? Check out our presentation for all the details! 📜 📩 𝗟𝗲𝘁’𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁—𝗿𝗲𝗮𝗰𝗵 𝗼𝘂𝘁 𝘁𝗼 𝘂𝘀 𝗮𝘁  businessdevelopment@reithera.com marketing@reithera.com

🌍 𝗨𝗻𝗶𝘁𝗲𝗱 𝗳𝗼𝗿 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝘁𝗵𝗲 𝗡𝗲𝘅𝘁 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗛𝗜𝗩 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀! 🌍 Last week, Stefania Capone, Marco Soriani, 𝗮𝗻𝗱 Angelo Raggioli, PhD from 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮 had the incredible opportunity to attend the 𝟮𝟬𝘁𝗵 𝗔𝗻𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗿𝘆 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗼𝗳 𝘁𝗵𝗲 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗔𝗜𝗗𝗦 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 (𝗖𝗔𝗩𝗗) 2025 in Dar Es Salaam, Tanzania (Feb 11-14). CAVD, established by the Gates Foundation in 2006, brings together a global network of experts working to advance HIV vaccines and biologics into clinical trials. And what better place to celebrate progress than alongside partners from 𝗥𝗮𝗴𝗼𝗻 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲, 𝗜𝗔𝗩𝗜, 𝗠𝘂𝘁𝗮𝗹𝗮 𝗧𝗿𝘂𝘀𝘁/𝗔𝗖𝗥𝗡, 𝗔𝗛𝗥𝗜, 𝗗𝗧𝗛𝗙, 𝗡𝗜𝗖𝗗, 𝗖𝗛𝗜𝗟, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗚𝗮𝘁𝗲𝘀 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻?🌍💡 At 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮, we are thrilled to be part of this collaboration as we move closer to launching a 𝗣𝗵𝗮𝘀𝗲 𝟭 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 in Southern Africa for 𝗚𝗥𝗔𝗱𝗛𝗜𝗩𝗡𝗘𝟭—an innovative HIV vaccine built on our clinically validated 𝗚𝗥𝗔𝗱 (𝗴𝗼𝗿𝗶𝗹𝗹𝗮 𝗮𝗱𝗲𝗻𝗼𝘃𝗶𝗿𝗮𝗹 𝘃𝗲𝗰𝘁𝗼𝗿) technology. Designed to elicit potent and durable CD8+ T cell responses, this platform holds promise not just for HIV but also for other 𝗰𝗵𝗿𝗼𝗻𝗶𝗰 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗮𝗻𝗱 𝗰𝗮𝗻𝗰𝗲𝗿 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀. A special shout-out to our partners at the 𝗥𝗮𝗴𝗼𝗻 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 for developing an advanced antigen targeting key 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝗮𝗹𝗹𝘆 𝗰𝗼𝗻𝘀𝘁𝗿𝗮𝗶𝗻𝗲𝗱 𝗖𝗗𝟴+ 𝗧 𝗰𝗲𝗹𝗹 𝗲𝗽𝗶𝘁𝗼𝗽𝗲𝘀 𝗳𝗿𝗼𝗺 𝗛𝗜𝗩 𝗰𝗹𝗮𝗱𝗲𝘀 𝗕 𝗮𝗻𝗱 𝗖. 🎯 The excitement was palpable at the CAVD meeting, where a dedicated session highlighted the extensive groundwork leading to this milestone. A huge step forward for our consortium and the future of HIV vaccines! 💪 #HIVResearch #VaccineDevelopment #CAVD2025 #GlobalHealth #ReiThera #CollaborationForACure